Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M504461200 on August 1, 2005

J. Biol. Chem., Vol. 280, Issue 39, 33558-33565, September 30, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/39/33558    most recent
M504461200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, L.
Right arrow Articles by Chang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, L.
Right arrow Articles by Chang, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Induction of Androgen Receptor Expression by Phosphatidylinositol 3-Kinase/Akt Downstream Substrate, FOXO3a, and Their Roles in Apoptosis of LNCaP Prostate Cancer Cells*

Lin Yang{ddagger}§1, Shaozhen Xie{ddagger}1, Md. Saha Jamaluddin¶, Saleh Altuwaijri{ddagger}, Jing Ni{ddagger}, Eungseok Kim{ddagger}, Yei-Tsung Chen{ddagger}, Yueh-Chiang Hu{ddagger}, Liang Wang{ddagger}, Kuang-Hsiang Chuang{ddagger}, Chun-Te Wu{ddagger}||, and Chawnshang Chang{ddagger}2

From the {ddagger}George Whipple Laboratory for Cancer Research, the Departments of Pathology, Urology, and Radiation Oncology and The Cancer Center, University of Rochester, Rochester, New York 14642, the §Department of Cancer Biology, M. D. Anderson Cancer Center, Houston, Texas 77054, the Department of Medicine, Section of Atherosclerosis, Baylor College of Medicine, Houston, Texas 77030, and the ||Department of Urology, Chang Gung University and Memorial Hospital, Taipei 105, Taiwan

The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays important roles for prostate cancer cell survival, and the androgen receptor (AR) plays essential roles for prostate cancer cell proliferation. How these two signals cooperate to control cell growth and death, however, remains unclear and debated. Here we provide the first linkage by the identification of Forkhead transcription factor FOXO3a, the PI3K/Akt downstream substrate, as a positive regulator for the induction of AR gene expression. Both Western blot and real time PCR assays demonstrate that FOXO3a can induce AR expression at the protein and mRNA levels, and gel shift and chromatin immunoprecipitation assays further demonstrate that FOXO3a can induce 5' AR promoter activity via binding to the consensus DNA-binding sequence in the AR 5' promoter -1290 to -1297 (5'-TTGTTTCA-3'). Under normal growth conditions, blocking PI3K/Akt signals by LY294002 causes LNCaP cell arrest in G1 phase rather than apoptosis. However, further blocking of AR functions by AR small interfering RNA leads to dramatic LNCaP cell death, suggesting that AR may play important protective roles when the PI3K/Akt signal pathway is blocked by LY294002. Together, our data provide the first model to explain how PI3K/Akt and AR can cooperate to control LNCaP cell growth and death under normal conditions.


Received for publication, April 25, 2005 , and in revised form, July 26, 2005.

* This work was supported by National Institutes of Health Grants CA55639, CA71870, DK67686, and DK60948, the George Whipple Professorship Endowment, and Dr. Shu-Shi Chang Neuroendocrinology Fund. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

2 To whom correspondence should be addressed. Tel.: 585-275-9994; E-mail: Chang{at}urmc.rochester.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
C. Cai, D. C. Portnoy, H. Wang, X. Jiang, S. Chen, and S. P. Balk
Androgen Receptor Expression in Prostate Cancer Cells Is Suppressed by Activation of Epidermal Growth Factor Receptor and ErbB2
Cancer Res., June 15, 2009; 69(12): 5202 - 5209.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, Z. Wang, D. Kong, R. Li, S. H. Sarkar, and F. H. Sarkar
Regulation of Akt/FOXO3a/GSK-3{beta}/AR Signaling Network by Isoflavone in Prostate Cancer Cells
J. Biol. Chem., October 10, 2008; 283(41): 27707 - 27716.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Snoeks, C. R. Weber, J. R. Turner, M. Bhattacharyya, K. Wasland, and S. D. Savkovic
Tumor Suppressor Foxo3a Is Involved in the Regulation of Lipopolysaccharide-Induced Interleukin-8 in Intestinal HT-29 Cells
Infect. Immun., October 1, 2008; 76(10): 4677 - 4685.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W.-C. Huang, J. J. Havel, H. E. Zhau, W. P. Qian, H.-W. Lue, C.-Y. Chu, T. Nomura, and L. W.K. Chung
{beta}2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells
Clin. Cancer Res., September 1, 2008; 14(17): 5341 - 5347.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Ponguta, C. W. Gregory, F. S. French, and E. M. Wilson
Site-specific Androgen Receptor Serine Phosphorylation Linked to Epidermal Growth Factor-dependent Growth of Castration-recurrent Prostate Cancer
J. Biol. Chem., July 25, 2008; 283(30): 20989 - 21001.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Li, Y.-F. Lee, S. Liu, Y. Cai, S. Xie, N.-C. Liu, B.-Y. Bao, Z. Chen, and C. Chang
Oxidative Stress Stimulates Testicular Orphan Receptor 4 through Forkhead Transcription Factor Forkhead Box O3a
Endocrinology, July 1, 2008; 149(7): 3490 - 3499.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Schayowitz, G. Sabnis, V. C.O. Njar, and A. M.H. Brodie
Synergistic effect of a novel antiandrogen, VN/124-1, and signal transduction inhibitors in prostate cancer progression to hormone independence in vitro
Mol. Cancer Ther., January 1, 2008; 7(1): 121 - 132.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, Z. Wang, D. Kong, S. Murthy, Q. P. Dou, S. Sheng, G. P. V. Reddy, and F. H. Sarkar
Regulation of FOXO3a/beta-Catenin/GSK-3beta Signaling by 3,3'-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Prostate Cancer Cells
J. Biol. Chem., July 20, 2007; 282(29): 21542 - 21550.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. M.R. Bhuiyan, Y. Li, S. Banerjee, F. Ahmed, Z. Wang, S. Ali, and F. H. Sarkar
Down-regulation of Androgen Receptor by 3,3'-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Both Hormone-Sensitive LNCaP and Insensitive C4-2B Prostate Cancer Cells.
Cancer Res., October 15, 2006; 66(20): 10064 - 10072.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement